• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有肾钙质沉着症和肾结石的成年人因原发性甲状旁腺功能亢进接受甲状旁腺切除术后仍持续高钙血症,病因是两种致病突变的新组合。

Persistent Hypercalcemia Despite Parathyroidectomy for Primary Hyperparathyroidism in an Adult with Nephrocalcinosis and Nephrolithiasis Caused by a Novel Combination of Two Pathogenic Mutations.

作者信息

Zhang Sijun, Muendlein Axel, Meusburger Edgar, Zitt Emanuel

机构信息

Department of Internal Medicine 3 (Nephrology, Dialysis and Hypertension), LKH Feldkirch, 6800 Feldkirch, Austria.

Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), 6800 Feldkirch, Austria.

出版信息

Int J Mol Sci. 2025 Sep 15;26(18):8965. doi: 10.3390/ijms26188965.

DOI:10.3390/ijms26188965
PMID:41009532
Abstract

Hypercalcemia is a frequent electrolyte disorder with a wide range of possible causes. While primary hyperparathyroidism is one of the most frequent causes, loss-of-function mutations in the gene, which encodes for the 24-hydroxylase enzyme responsible for the catabolism of 25(OH)D and 1,25(OH)D, have been described as a rare cause of hypercalcemia associated with nephrocalcinosis and nephrolithiasis due to the reduced degradation of vitamin D metabolites. We describe an interesting case of a 67-year-old woman who suffered from hypercalcemia with nephrocalcinosis and nephrolithiasis caused by the simultaneous presence of these two conditions. At the first presentation, primary hyperparathyroidism due to parathyroid adenoma was found to be causative, with partial parathyroidectomy leading to temporary normocalcemia. As hypercalcemia reappeared, an elevated 25(OH)D/24,25(OH)D3 ratio and consequently a novel combination of two pathogenic heterozygous missense mutations (c.1186C>T and c.628T>C) of the gene were found. This case highlights the diagnostic complexity of persistent hypercalcemia and underscores the importance of also considering rare causes such as mutations in the differential diagnosis after the exclusion of relevant frequent disease causes.

摘要

高钙血症是一种常见的电解质紊乱,可能病因广泛。虽然原发性甲状旁腺功能亢进是最常见的病因之一,但编码负责25(OH)D和1,25(OH)D分解代谢的24-羟化酶的基因功能丧失突变,已被描述为高钙血症的一种罕见病因,由于维生素D代谢产物降解减少,可导致肾钙质沉着症和肾结石。我们描述了一例有趣的病例,一名67岁女性因同时存在这两种情况而患有高钙血症并伴有肾钙质沉着症和肾结石。在首次就诊时,发现由甲状旁腺腺瘤引起的原发性甲状旁腺功能亢进是病因,部分甲状旁腺切除术后血钙暂时恢复正常。随着高钙血症再次出现,发现25(OH)D/24,25(OH)D3比值升高,因此发现了该基因的两种致病性杂合错义突变(c.1186C>T和c.628T>C)的新组合。该病例突出了持续性高钙血症的诊断复杂性,并强调了在排除相关常见疾病病因后,在鉴别诊断中考虑罕见病因(如该基因突变)的重要性。

相似文献

1
Persistent Hypercalcemia Despite Parathyroidectomy for Primary Hyperparathyroidism in an Adult with Nephrocalcinosis and Nephrolithiasis Caused by a Novel Combination of Two Pathogenic Mutations.一名患有肾钙质沉着症和肾结石的成年人因原发性甲状旁腺功能亢进接受甲状旁腺切除术后仍持续高钙血症,病因是两种致病突变的新组合。
Int J Mol Sci. 2025 Sep 15;26(18):8965. doi: 10.3390/ijms26188965.
2
Vesicoureteral Reflux膀胱输尿管反流
3
Persistent hypercalcaemia associated with two pathogenic variants in the gene and a parathyroid adenoma-a case report and review.与基因中的两个致病性变异体和甲状旁腺腺瘤相关的持续性高钙血症:病例报告及文献复习。
Front Endocrinol (Lausanne). 2024 Apr 11;15:1355916. doi: 10.3389/fendo.2024.1355916. eCollection 2024.
4
-Related Disorders相关疾病
5
Parathyroidectomy for adults with primary hyperparathyroidism.甲状旁腺切除术治疗原发性甲状旁腺功能亢进症成人患者。
Cochrane Database Syst Rev. 2023 Mar 8;3(3):CD013035. doi: 10.1002/14651858.CD013035.pub2.
6
Infantile hypercalcemia type 1 (HCINF1): a rare disease resulting in nephrolithiasis and nephrocalcinosis caused by mutations in the vitamin D catabolic enzyme, CYP24A1.婴儿型高钙血症 1 型(HCINF1):一种罕见疾病,由维生素 D 代谢酶 CYP24A1 突变引起,导致肾结石和肾钙质沉着症。
J Endocrinol Invest. 2024 Nov;47(11):2663-2670. doi: 10.1007/s40618-024-02381-8. Epub 2024 May 23.
7
Hypercalcaemic crisis due to primary hyperparathyroidism - a systematic literature review and case report.原发性甲状旁腺功能亢进导致高钙血症危象:系统文献回顾及病例报告。
Endokrynol Pol. 2012;63(6):494-502.
8
Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.CYP24A1 基因(维生素 D24-羟化酶基因)的功能丧失性突变可导致长期存在的高钙尿性肾结石和肾钙质沉着症。
J Urol. 2013 Aug;190(2):552-7. doi: 10.1016/j.juro.2013.02.3188. Epub 2013 Mar 5.
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
Comparison of the two treatment methods in primary hyperparathyroidism due to solitary parathyroid adenoma, Ultrasound-guided percutaneous alcohol ablation vs. parathyroidectomy: a randomized controlled trial.超声引导下经皮酒精消融术与甲状旁腺切除术治疗孤立性甲状旁腺腺瘤所致原发性甲状旁腺功能亢进的两种治疗方法比较:一项随机对照试验
BMC Endocr Disord. 2025 Jan 24;25(1):19. doi: 10.1186/s12902-025-01836-0.

本文引用的文献

1
Targeting Calcitriol Metabolism in Acute Vitamin D Toxicity-A Comprehensive Review and Clinical Insight.靶向急性维生素 D 毒性中的钙三醇代谢:全面综述和临床观察。
Int J Mol Sci. 2024 Sep 17;25(18):10003. doi: 10.3390/ijms251810003.
2
Persistent hypercalcaemia associated with two pathogenic variants in the gene and a parathyroid adenoma-a case report and review.与基因中的两个致病性变异体和甲状旁腺腺瘤相关的持续性高钙血症:病例报告及文献复习。
Front Endocrinol (Lausanne). 2024 Apr 11;15:1355916. doi: 10.3389/fendo.2024.1355916. eCollection 2024.
3
Severe Hypercalcemia Due to Primary Hyperparathyroidism and Heterozygous Pathogenic Variant of CYP24A1.
原发性甲状旁腺功能亢进症和CYP24A1杂合致病变异导致的严重高钙血症
JCEM Case Rep. 2023 Aug 9;1(4):luad071. doi: 10.1210/jcemcr/luad071. eCollection 2023 Jul.
4
Hypervitaminosis D Secondary to a Loss-of-Function Mutation: An Unusual Cause of Hypercalcemia in Two Siblings.功能丧失性突变继发维生素D过多症:两例同胞高钙血症的罕见病因
JBMR Plus. 2023 Aug 8;7(9):e10788. doi: 10.1002/jbm4.10788. eCollection 2023 Sep.
5
Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review.由于 CYP24A1 突变导致的高钙血症:系统描述性综述。
Eur J Endocrinol. 2021 Dec 10;186(2):137-149. doi: 10.1530/EJE-21-0713.
6
24-Hydroxylase Deficiency Due to Sequence Variants: Comparison With Other Vitamin D-mediated Hypercalcemia Disorders.序列变异导致的24-羟化酶缺乏:与其他维生素D介导的高钙血症疾病的比较。
J Endocr Soc. 2021 Jul 2;5(9):bvab119. doi: 10.1210/jendso/bvab119. eCollection 2021 Sep 1.
7
Therapy-Resistant Hypercalcemia in a Patient with Inactivating CYP24A1 Mutation and Recurrent Nephrolithiasis: Beware of Concomitant Hyperparathyroidism.伴有 CYP24A1 失活突变和复发性肾结石的治疗抵抗性高钙血症患者:警惕同时存在的甲状旁腺功能亢进症。
Calcif Tissue Int. 2020 Nov;107(5):524-528. doi: 10.1007/s00223-020-00738-8. Epub 2020 Aug 2.
8
Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update.原发性甲状旁腺功能亢进症中的分子遗传学:基因检测在鉴别诊断、疾病预防策略及治疗规划中的作用。2017年更新版。
Clin Cases Miner Bone Metab. 2017 Jan-Apr;14(1):60-70. doi: 10.11138/ccmbm/2017.14.1.060. Epub 2017 May 30.
9
CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.利福平对CYP3A4的诱导作用:CYP24A1突变患者维生素D失活的另一条途径
J Clin Endocrinol Metab. 2017 May 1;102(5):1440-1446. doi: 10.1210/jc.2016-4048.
10
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.维生素D介导的高钙血症:机制、诊断与治疗
Endocr Rev. 2016 Oct;37(5):521-547. doi: 10.1210/er.2016-1070. Epub 2016 Sep 2.